Clinical trial Recruiting at 1 site Observational Ages 18 to 45

Anger, Social Thinking, and PTSD in French Veterans

Official title: Anger, Social Cognition and Post-traumatic Stress Disorder in Former French Military Personnel

Run by Direction Centrale du Service de Santé des Armées · NCT07851090 · Data updated 2026-11-12

This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexAll
Enrollment150 (estimated)
SponsorDirection Centrale du Service de Santé des Armées
Academic / other
Locations1 site (Draguignan)
StatusRecruiting
StartedMay 30, 2025
Main results expectedNovember 30, 2029
Study endsNovember 30, 2029
Registry record updatedOctober 1, 2026
Trial IDNCT07851090 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are French veterans aged 18–45 with PTSD and a PMI of 20% or more who can speak French and participate in online and/or interview assessments.

Probably not a fit

Participants without PTSD or not meeting inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, cross-sectional observational study of French veterans with PTSD. It uses mediation analyses to explore whether PTSD influences anger indirectly via social cognitive abilities, and it qualitatively examines how alcohol use and ACE affect social cognition components. A second qualitative aim investigates moral harms reported by participants through semi-structured interviews. Recruitment involves the Pension and Occupational Risks Service sending invitations, followed by informed consent and online assessments, with a subset undergoing interviews.

Why it matters

Potential benefit: If successful, findings could clarify how PTSD affects anger and social cognition, informing targeted support for veterans.

How similar studies have gone: Previous work suggests links between PTSD, social cognition, and anger, but this specific mediation model in French veterans is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be of legal age and between 18 and 45 years old;
* Be able to speak, read, and write French;
* Have given oral consent after receiving an oral explanation of the study's objectives and procedures;
* Sign a written, informed, and electronic consent form after reviewing an information sheet explaining the study's objectives and procedures;
* Be enrolled in a social security program;
* Receive a military disability pension (PMI) (temporary or permanent) of 20% or more.

Additional criterion for the qualitative component: reporting having been exposed to events that could be morally harmful (verified through a specific question in the sociodemographic questionnaire).

Exclusion Criteria:

Pregnant and breastfeeding women;

* Minors;
* Individuals under administrative or judicial supervision;
* Adults under legal guardianship;
* Reservists who have not previously served on active duty;
* Individuals who cannot be contacted in an emergency;
* Physical conditions related to trauma, including head injuries;
* Participants with a comorbid psychotic disorder;
* Participants who regularly use illicit drugs

Where it's running

  • Marmuse Anaïs
    Draguignan, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.